TMC Medical Minutes: Cervical Cancer

Posted: Mon 3:51 PM, Sep 08, 2008

Every year, close to 11,000 women in the United States are diagnosed with cervical cancer. Obstetrician and Gynecologist, Dr. Jeffrey Hermann joins us to discuss the importance of getting screened.

Polio-like illnesses called a 'rare phenomenon'

Comments are posted from viewers like you and do not always reflect the views of this station.

WebMD Health News

2 Surgeries Work Equally Well for Female Incontinence, Study Finds

Doctors can choose the one they're more familiar with, expert says
Whole-Genome Scans Not Quite Ready for Widespread Use: Study

Tests are promising but not yet reliable enough, experts say
Healthy Breakfasts and Citrus Granola

WebMD explains why a good breakfast is the healthy way to start the day. Plus, Domenica Cattelli's Citrus and Nut Granola recipe.
8 Fun Facts About Pineapple

WebMD has info on the history, cultivation, and health benefits of pineapple. Plus a delicious shrimp and pineapple kabob recipe!
Knee Pain May Not Be Helped by Glucosamine

Popular supplement did not reduce cartilage damage or improve joint function in study

AP Top Health Stories

Obama pitches his health care plan on Funny or Die

NEW YORK (AP) — Zach Galifianakis brought the ferns, and President Barack Obama opened a new avenue of presidential communication.
Gene mapping study shows promise, challenges
CHICAGO (AP) — These days, it's faster and cheaper than ever to decipher a person's entire DNA. But a small study suggests that looking for disease risks that way may not be ready for the masses.
Study: 2 percent of Americans have new hips, knees

It's not just grandma with a new hip and your uncle with a new knee. More than 2 of every 100 Americans now have an artificial joint, doctors are reporting.
Rohingya dying from lack of health care in Myanmar

THE' CHAUNG, Myanmar (AP) — Noor Jahan rocked slowly on the floor, trying to steady her weak body. Her chest heaved and her eyes closed with each raspy breath. She could no longer eat or speak, throwing up even spoonfuls of tea.
AstraZeneca sells British R&D site, to take 165.50 million pounds charge
AstraZeneca has agreed to sell its Alderley Park research site in northern England to a public-private partnership group as it moves drug discovery to a new global centre in Cambridge. The decision to close Alderley Park was a major blow for the northwest of the country, but the latest transaction has a silver lining as new owner Manchester Science Parks plans to keep the 400-acre site as a biotechnology campus. The site lies with within the Cheshire parliamentary constituency of British Finance Minister George Osborne, who said on Wednesday he was delighted it would continue to play a role as a centre for the life sciences industry. The sale follows a decision last March by AstraZeneca Chief Executive Pascal Soriot to move drug research and development to a new site in university city Cambridge in eastern England - a world-class centre for life sciences.